Enrolling by invitationNCT06227962

Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors

Studying Hereditary retinoblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Amsterdam University Medical Center
Principal Investigator
Annette C. Moll, MD PhD
Amsterdam University Medical Center
Intervention
Neuropsychological assesment(diagnostic_test)
Enrollment
240 enrolled
Eligibility
35 years · All sexes
Timeline
2023 – 2028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06227962 on ClinicalTrials.gov

Other trials for Hereditary retinoblastoma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary retinoblastoma →

← Back to all trials